Pro Medicus (ASX:PME) share price jumps on Apple Vision Pro update
The Pro Medicus Ltd (ASX:PME) share price has gone up 4% after the ASX healthcare share revealed Visage Ease VP for Apple Vision Pro.
Changes are happening - please bear with us while we update our site. Click here to give us your advice and feedback.
The Pro Medicus Ltd (ASX:PME) share price has gone up 4% after the ASX healthcare share revealed Visage Ease VP for Apple Vision Pro.
Here’s today’s The Match Out report from Market Matters’ James Gerrish. Key point: the S&P/ASX 200 (INDEXASX: XJO) finished up +1.47% to 7,699.40.
The S&P/ASX 200 (INDEXASX: XJO) Index could not hold on to yesterday’s record close, dropping 92.5 points, or 1.2 per cent, to 7,588.2 points, with all 11 industry sub-indices losing ground.
Here’s today’s The Match Out report from Market Matters’ James Gerrish. Key point: the S&P/ASX 200 (INDEXASX: XJO) finished down -1.20% to 7,588.20.
A deep dive into ResMed Inc (ASX: RMD) shares and Magellan Financial Group Ltd (ASX: MFG) shares by Rask’s Chief Investment Officer, Owen Rask.
The benchmark S&P/ASX 200 (INDEXASX: XJO) closed up 80.5 points, or 1.1 per cent, to 7,680.7 – 51.8 points, or 0.7 per cent, above the previous closing record of 7,628.9 points, which was reached in August 2021. The broader All Ordinaries (INDEXASX: XAO) index added 77.8 points, or 1 per cent, to 7,912.8.
Here’s today’s The Match Out report from Market Matters’ James Gerrish. Key point: the S&P/ASX 200 (INDEXASX: XJO) finished up +1.06% to 7,680.70.
Shares in pharmaceutical distribution company Sigma Healthcare Ltd (ASX: SIG) were on the move in December, rising 45% following the news of a potential $9 billion merger with Chemist Warehouse Group. SIG shares are in the spotlight again today, up a further 7% today.
The benchmark S&P/ASX 200 (INDEXASX: XJO) index added 21.8 points, or 0.3 per cent, to 7600.2 at the closing bell, with seven out of the 11 sectors finishing in the green. The All Ordinaries (INDEXASX: XAO) edged up 0.3 per cent.
The Pro Medicus Ltd (ASX:PME) share price has gone up 4% after the ASX healthcare share revealed Visage Ease VP for Apple Vision Pro.
Here’s today’s The Match Out report from Market Matters’ James Gerrish. Key point: the S&P/ASX 200 (INDEXASX: XJO) finished up +1.47% to 7,699.40.
The S&P/ASX 200 (INDEXASX: XJO) Index could not hold on to yesterday’s record close, dropping 92.5 points, or 1.2 per cent, to 7,588.2 points, with all 11 industry sub-indices losing ground.
Here’s today’s The Match Out report from Market Matters’ James Gerrish. Key point: the S&P/ASX 200 (INDEXASX: XJO) finished down -1.20% to 7,588.20.
A deep dive into ResMed Inc (ASX: RMD) shares and Magellan Financial Group Ltd (ASX: MFG) shares by Rask’s Chief Investment Officer, Owen Rask.
The benchmark S&P/ASX 200 (INDEXASX: XJO) closed up 80.5 points, or 1.1 per cent, to 7,680.7 – 51.8 points, or 0.7 per cent, above the previous closing record of 7,628.9 points, which was reached in August 2021. The broader All Ordinaries (INDEXASX: XAO) index added 77.8 points, or 1 per cent, to 7,912.8.
Here’s today’s The Match Out report from Market Matters’ James Gerrish. Key point: the S&P/ASX 200 (INDEXASX: XJO) finished up +1.06% to 7,680.70.
Shares in pharmaceutical distribution company Sigma Healthcare Ltd (ASX: SIG) were on the move in December, rising 45% following the news of a potential $9 billion merger with Chemist Warehouse Group. SIG shares are in the spotlight again today, up a further 7% today.
The benchmark S&P/ASX 200 (INDEXASX: XJO) index added 21.8 points, or 0.3 per cent, to 7600.2 at the closing bell, with seven out of the 11 sectors finishing in the green. The All Ordinaries (INDEXASX: XAO) edged up 0.3 per cent.
Want to level-up your analytical skills and investing insights but don’t know where to start? We can help. Join 40,000+ Australian investors on our mailing list today and we’ll send you our favourite podcasts, courses, resources, investment articles and podcasts every week. Delivered to your inbox every Sunday morning. Grab a coffee and let Owen and the team bring you the best investment insights every week.